FR2304354A1 - Nouvelles compositions pharmaceutiques a activite retardee - Google Patents

Nouvelles compositions pharmaceutiques a activite retardee

Info

Publication number
FR2304354A1
FR2304354A1 FR7607363A FR7607363A FR2304354A1 FR 2304354 A1 FR2304354 A1 FR 2304354A1 FR 7607363 A FR7607363 A FR 7607363A FR 7607363 A FR7607363 A FR 7607363A FR 2304354 A1 FR2304354 A1 FR 2304354A1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
new pharmaceutical
delayed activity
delayed
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7607363A
Other languages
English (en)
French (fr)
Other versions
FR2304354B1 (xx
Inventor
Prabhakar Ranchhordas Sheth
Jacques Levon Tossounian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of FR2304354A1 publication Critical patent/FR2304354A1/fr
Application granted granted Critical
Publication of FR2304354B1 publication Critical patent/FR2304354B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7607363A 1975-03-17 1976-03-15 Nouvelles compositions pharmaceutiques a activite retardee Granted FR2304354A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
FR2304354A1 true FR2304354A1 (fr) 1976-10-15
FR2304354B1 FR2304354B1 (xx) 1979-04-27

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7607363A Granted FR2304354A1 (fr) 1975-03-17 1976-03-15 Nouvelles compositions pharmaceutiques a activite retardee

Country Status (21)

Country Link
JP (1) JPS51115910A (xx)
AR (1) AR222624A1 (xx)
AT (1) AT353415B (xx)
AU (1) AU505355B2 (xx)
CA (1) CA1073358A (xx)
CH (1) CH630257A5 (xx)
DD (1) DD124102A5 (xx)
DE (1) DE2611041A1 (xx)
DK (1) DK148344C (xx)
ES (1) ES446075A1 (xx)
FR (1) FR2304354A1 (xx)
GB (1) GB1546448A (xx)
GR (1) GR60341B (xx)
IE (1) IE43083B1 (xx)
LU (1) LU74558A1 (xx)
MC (1) MC1101A1 (xx)
NL (1) NL190313C (xx)
NZ (1) NZ180321A (xx)
PH (1) PH14927A (xx)
PT (1) PT64907B (xx)
SE (1) SE433804B (xx)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504802A1 (fr) * 1981-04-29 1982-11-05 Hoffmann La Roche Preparations pharmaceutiques a liberation reglee
FR2512676A1 (fr) * 1981-09-14 1983-03-18 Hoffmann La Roche Composition a liberation commandee hydrodynamiquement equilibree
DE3505743A1 (de) * 1984-02-29 1985-08-29 Sandoz-Patent-GmbH, 7850 Lörrach Bromocriptin enthaltende zusammensetzungen
DE3602577A1 (de) * 1985-02-05 1986-08-28 Sandoz-Patent-GmbH, 7850 Lörrach 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen
DE3632201A1 (de) * 1985-10-01 1987-04-02 Sandoz Ag Pharmazeutische zusammensetzungen mit kontrollierter freisetzung des wirkstoffes
FR2613224A1 (fr) * 1987-04-06 1988-10-07 Alza Corp Forme posologique bicouche a liberation prolongee
EP0396425A2 (en) * 1989-05-05 1990-11-07 Kv Pharmaceutical Company Extended release pharmaceutical formulations
WO1993018755A1 (en) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
FR2820318A1 (fr) * 2001-02-08 2002-08-09 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
WO2002062321A2 (fr) * 2001-02-08 2002-08-15 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
JP2626248B2 (ja) * 1991-04-08 1997-07-02 日本新薬株式会社 カプセル剤
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
WO1995031186A1 (en) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Method and composition for increasing calcium uptake
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2263744A1 (xx) * 1974-03-12 1975-10-10 Eisai Co Ltd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2263744A1 (xx) * 1974-03-12 1975-10-10 Eisai Co Ltd

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504802A1 (fr) * 1981-04-29 1982-11-05 Hoffmann La Roche Preparations pharmaceutiques a liberation reglee
FR2512676A1 (fr) * 1981-09-14 1983-03-18 Hoffmann La Roche Composition a liberation commandee hydrodynamiquement equilibree
DE3505743A1 (de) * 1984-02-29 1985-08-29 Sandoz-Patent-GmbH, 7850 Lörrach Bromocriptin enthaltende zusammensetzungen
FR2560047A1 (fr) * 1984-02-29 1985-08-30 Sandoz Sa Compositions de bromocriptine
DE3602577A1 (de) * 1985-02-05 1986-08-28 Sandoz-Patent-GmbH, 7850 Lörrach 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen
DE3632201A1 (de) * 1985-10-01 1987-04-02 Sandoz Ag Pharmazeutische zusammensetzungen mit kontrollierter freisetzung des wirkstoffes
FR2613224A1 (fr) * 1987-04-06 1988-10-07 Alza Corp Forme posologique bicouche a liberation prolongee
GR880100214A (en) * 1987-04-06 1989-01-31 Alza Corp Dosage form comprising parallel laminare
BE1001699A3 (fr) * 1987-04-06 1990-02-13 Alza Corp Forme de dosage comprenant des lamelles paralleles.
EP0396425A2 (en) * 1989-05-05 1990-11-07 Kv Pharmaceutical Company Extended release pharmaceutical formulations
EP0396425A3 (en) * 1989-05-05 1992-11-19 Kv Pharmaceutical Company Extended release pharmaceutical formulations
WO1993018755A1 (en) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
FR2820318A1 (fr) * 2001-02-08 2002-08-09 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
WO2002062321A2 (fr) * 2001-02-08 2002-08-15 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine
WO2002062321A3 (fr) * 2001-02-08 2003-02-27 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine

Also Published As

Publication number Publication date
AR222624A1 (es) 1981-06-15
DD124102A5 (xx) 1977-02-02
IE43083L (en) 1976-09-17
DK148344B (da) 1985-06-17
DK113676A (da) 1976-09-18
DK148344C (da) 1985-11-04
FR2304354B1 (xx) 1979-04-27
JPS638084B2 (xx) 1988-02-19
PT64907B (fr) 1978-03-24
AU505355B2 (en) 1979-11-15
AU1204976A (en) 1977-09-22
JPS51115910A (en) 1976-10-13
CA1073358A (en) 1980-03-11
SE7603325L (sv) 1976-09-18
NL190313B (nl) 1993-08-16
GB1546448A (en) 1979-05-23
GR60341B (en) 1978-05-17
AT353415B (de) 1979-11-12
ATA192276A (de) 1979-04-15
NZ180321A (en) 1978-06-20
DE2611041A1 (de) 1976-10-14
ES446075A1 (es) 1977-09-16
MC1101A1 (fr) 1977-02-04
NL190313C (nl) 1994-01-17
NL7602776A (nl) 1976-09-21
LU74558A1 (xx) 1977-09-27
DE2611041C2 (xx) 1988-06-09
IE43083B1 (en) 1980-12-17
SE433804B (sv) 1984-06-18
PH14927A (en) 1982-01-29
CH630257A5 (en) 1982-06-15
PT64907A (fr) 1976-04-01

Similar Documents

Publication Publication Date Title
FR2304354A1 (fr) Nouvelles compositions pharmaceutiques a activite retardee
BE852445A (fr) Nouvelles compositions pharmaceutiques anti-inflammatoires
BE840307A (fr) Carbodimides
AT346126B (de) Insektizides mittel
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
BE871584A (fr) Preparations pharmaceutiques
BE826086A (fr) Preparation pharmaceutique orale a activite androgene
NL7606655A (nl) Imidylbenzeendi- en -tricarbonzuurderivaten.
AT346649B (de) Insektizides mittel
AT346646B (de) Insektizides mittel
PT65949A (pt) Pharmacologically active compounds
IT1070839B (it) Composto farmacologicamente attivi
DK116576A (da) Salicylanilidderivater
BE856811A (fr) Compositions pharmaceutiques basiques renfermant un preservateur
SE7609339L (sv) Farmaceutiska bassalter
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
AT346650B (de) Insektizides mittel
BE826935A (fr) Compositions pharmaceutiques antivirales
BE824341A (fr) Compositions pharmaceutiques a activite analgesique
BE840866A (fr) Composition therapeutique a activite anti-agregante plaquettaire
SE7608478L (sv) Farmaceutica
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
FR2326189A2 (fr) Composition pharmaceutique
BE838507A (fr) Comprimes pharmaceutiques
FR2313053A1 (fr) Nouvelles thiazolinones

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0123, 920430

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0123, 760315

CL Concession to grant licences